Skip to main content
logo
OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
3.334
-0.010 (-0.30%)
Aug 21, 2026, 5:35 PM CET

OSE Immunotherapeutics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.692.6983.442.2318.326.31
Revenue Growth
-96.78%-96.78%3646.52%-87.83%-30.43%152.48%
Gross Profit
2.392.3983.092.2318.326.31
Operating Income
-37.49-37.4943.74-22.99-18.48-16.63
Net Income
-37.69-37.6937.45-23-17.76-16.85
Earnings Per Share
-1.69-1.691.46-1.18-0.96-0.93
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
22.6522.6559.1218.6725.6233.58
Total Debt
36.2936.2946.1345.844.7937.13
Net Cash (Debt)
-13.65-13.6512.99-27.13-19.17-3.55
Net Cash Growth
------
Net Cash Per Share
-0.61-0.610.51-1.39-1.03-0.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-34.03-34.0348.44-19.76-18.25-9.92
Capital Expenditures
-0.1-0.1-0.08-0.02-0.27-0.47
Free Cash Flow
-34.13-34.1348.36-19.78-18.53-10.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
88.70%88.70%99.59%100.00%100.00%100.00%
Operating Margin
-1392.98%-1392.98%52.42%-1032.15%-100.96%-63.20%
Pretax Margin
-1390.34%-1390.34%47.74%-1042.75%-98.48%-65.44%
Profit Margin
-1400.56%-1400.56%44.88%-1032.91%-97.04%-64.05%
FCF Margin
-1268.38%-1268.38%57.97%-888.19%-101.22%-39.50%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--4.19---
Forward PE
-11.122.8393.6693.6693.66
P/FCF Ratio
--3.24---
PS Ratio
29.1442.911.8836.176.747.14